Global Morpho Pharma

  • Booth: 565


Highly reliable partners for GMP radiopharmaceuticals

Global Morpho Pharma SAS (Dr Richard Zimmerman / GM and Founder www.morphopharma.com ), a new radiopharmaceutical company from France, founded to meet the market demand for high-quality radionuclides suitable for medical applications. The company created in early 2018 aims at developing, distributing, radionuclides and radiopharmaceuticals under Good Manufacturing Practice (GMP) Their partner in North and South America, is SPECTRONRx which provides therapeutic and diagnostic Isotopes for clinical and research use and provides Contract Manufacturing Services. SPECTRONRx (ww.spectronrx.com) is an approved FDA manufacturer of Radioactive drugs with three active ANDA’s. With its combined century plus experience in the imaging sciences this group has come together to better the production, processing and availability of critically needed radionuclides. Together we are building a worldwide network of centers covering the entire supply chain, from the original target to the pharmaceutical grade radionuclide for human use, eventually to the final ready-to-use drug. SPECTRONRx & Global Morpho Pharma (GMP) together point clearly to their mission and core beliefs: Quality, Reliability, Sustainability. Come and visit us at booth # 565

Brands: We have an NRC license giving us the ability to handle multiple isotopes including Lu-177, Ac-225, I-131, I-124, Copper-64 and Fluorine 18.


 Products

For Technical Support with this webpage, please contact support.